J. Wale

J. Wale, J. Belizán, M. Belizán, 2010, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

A call for action to improve access to care and treatment for patients with rare diseases in the Asia-Pacific region

J. Wale, B. Ko, H. Wee, 2014, Orphanet Journal of Rare Diseases.

Where National Medicines Policies Have Taken Us With Patient Involvement and Health Technology Assessment in Africa

J. Wale, K. Sehmi, 2022, Frontiers in Medical Technology.

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

Andy Gray, Brian Godman, Ilse Truter, 2015, Expert review of clinical pharmacology.

Initiatives among Authorities to Improve the Quality and Efficiency of Prescribing and the Implications

Brian Godman, Ilse Truter, Andrew Martin, 2016 .

Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

A. Haycox, S. Simoens, R. Malmström, 2013, Front. Pharmacol..

Pricing of oral generic cancer medicines in 25 European countries; findings and implications

Steven Simoens, Brian Godman, Guenka Petrova, 2019, Generics and Biosimilars Initiative Journal.

Patients and public are important stakeholders in health technology assessment but the level of involvement is low – a call to action

J. Wale, S. Thomas, D. Hamerlijnck, 2021, Research Involvement and Engagement.

International Health Consumers in The Cochrane Collaboration: Fifteen Years On

J. Wale, C. Colombo, M. Belizán, 2010, The Journal of ambulatory care management.

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

S. Simoens, L. Gustafsson, J. Wale, 2021, Expert review of pharmacoeconomics & outcomes research.

Response to ‘A survey of suppression of public health information by Australian governments’

J. Wale, A. Mckenzie, I. Hill, 2008, Australian and New Zealand journal of public health.

Civil society and medical product access in Africa: Lessons from COVID-19

J. Wale, R. Ssekubugu, Regina Kamoga, 2023, Frontiers in Medical Technology.

Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations

C. Schneider, J. Wale, S. Nielsen, 2023, The Medical journal of Australia.

Development of the effective musculoskeletal consumer scale.

Cindy Gallois, Nancy Santesso, Elizabeth Kristjansson, 2007, The Journal of rheumatology.

Attributes and skills of an effective musculoskeletal consumer.

Cindy Gallois, Nancy Santesso, Janet Wale, 2005, The Journal of rheumatology.

An investigation into the usability of a drug-complementary medicines interactions database in a consumer group of women with breast cancer

S. Venkatraman, J. Wale, K. O’Brien, 2020 .

Responsiveness of the Effective Consumer Scale (EC-17)

P. Tugwell, V. Welch, E. Kristjansson, 2009, The Journal of Rheumatology.

Can We Afford to Exclude Patients Throughout Health Technology Assessment?

D. Collyar, J. Wale, D. Chandler, 2022, Frontiers in Medical Technology.

The ASTUTE Health study protocol: Deliberative stakeholder engagements to inform implementation approaches to healthcare disinvestment

Janet Wale, J. Wale, H. Buchan, 2012, Implementation Science.